Abstract:Background: Acute myeloid leukemia (AML) originates in the bone marrow, evading immune recognition and destruction. The bone marrow microenvironment (BME), comprising diverse immune cells and regulators, profoundly influences AML development. However, the impact of immune regulators in the BME, particularly on T-cell anti-AML immunity, remains inadequately understood. Therefore, evaluating the impact of immune regulators in the AML bone marrow microenvironment on T cell dysfunction is of paramount importance and necessity. M ethod : Bone marrow blood samples were obtained from pediatric AML patients at diagnosis and age-matched healthy individuals considered as hematopoietic stem cell transplantation (HSCT) donors after written informed consent. By centrifuging at 2000-3000rpm for 10min, we obtained the supernatant as plasma and stored it in a -80°C refrigerator. After using proteomics to identify the expression of 180 immune regulatory factors in plasma samples, we performed GO and KEGG functional enrichment analysis. After density gradient centrifugation, we isolated bone marrow mononuclear cells (BMMNCs) and immediately identified frequencies of T cell populations and expression levels of functional markers by flow cytometry when they were fresh. Moreover, the co-culture model of CD8 +T cells and THP-1 cell line was used to evaluate the anti-AML effector function of T cells. CD8 +T cells in BMMNCs were sorted by FACS and then subjected to whole transcriptome sequencing and in vitro experiments. After using the TRRUST and KnockTF databases for transcription factor prediction analysis, we selected phospho-flow cytometry to detect and verify the association between the level of phosphorylation of transcription factors and the function of CD8 +T cells. The data were analyzed using R software. Results: Using proteomics techniques, we uncovered a substantial presence of immune-suppressive regulatory factors in AML bone marrow plasma. Interestingly, the canonical NF-κB pathway, mediated by immune regulators and vital for immune regulation in BME, displayed significant downregulation, implying T-cell dysfunction. In our investigation, we identified dysfunctional CD8 +T cells in the primary AML bone marrow, characterized by heightened expression of co-inhibitory receptors and pro-dysfunctional transcription factors, as well as significantly decreased anti-AML effector function. Transcriptome sequencing further linked AML CD8 +T cell dysfunction to reduced transcriptional activity of NF-κB p65 in the canonical NF-κB signaling pathway. Intriguingly, in vitro inhibition of NF-κB p65 and its phosphorylation led to elevated expression of exhaustion markers, such as PD-1, LAG-3, and TIM-3 on primary CD8 +T cells. Most notably, the stimulation of the canonical NF-κB signaling pathway effectively restored activation and effector function-related pathways in dysfunctional AML CD8 +T cells. Conclusion: Immune regulators in the bone marrow microenvironment play a vital role in maintaining dysfunctional AML CD8 +T cells. These findings provide a novel strategy to investigate the potential mechanisms and interventions for T-cell dysfunction.

Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia

Hyperfunction of CD4 CD25 Regulatory T Cells in De Novo Acute Myeloid Leukemia.

Dysregulation of Immune Regulators in AML Bone Marrow Promotes Dysfunction of CD8 + T Cells

Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia.

Increased Population of CD4(+)CD25(high), Regulatory T Cells with Their Higher Apoptotic and Proliferating Status in Peripheral Blood of Acute Myeloid Leukemia Patients.

Expression of Novel Regulatory Cell Subsets of PD-1high Foxp3+ Γδ T Cells in De Novo AML

Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (Tnf)-Α–tnf Receptor-2 Pathway

Research progress of regulatory T cells in acute myeloid leukemia

The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia

Increase of Cd4(+)Cd25(High) Regulatory T Cells in the Peripheral Blood of Acute Myeloid Leukemia Patients.

Intracellular Cytokine Expression Characteristics of Activated T Lymphocytes in Patients with Acute Myeloid Leukemia

Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review

[Treg Cells, FoxP3 and TGF-β Expression and Significance in Chronic Myeloid Leukemia].

The Imbalanced Profile and Clinical Significance of T Helper Associated Cytokines in Bone Marrow Microenvironment of the Patients with Acute Myeloid Leukemia

A Skewed Distribution and Increased PD-1+Vβ+CD4+/CD8+ T Cells in Patients with Acute Myeloid Leukemia

Higher Frequency of the CTLA‐4+LAG‐3+ T‐cell Subset in Patients with Newly Diagnosed Acute Myeloid Leukemia

Study on the value of Foxp3 + Tregs level in peripheral blood of patients with relapsed and refractory acute lymphoblastic leukemia after CAR-T cell therapy

Aberrant T Helper 17 Cells and Related Cytokines in Bone Marrow Microenvironment of Patients with Acute Myeloid Leukemia

The Profile Of T Helper Subsets In Bone Marrow Microenvironment Is Distinct For Different Stages Of Acute Myeloid Leukemia Patients And Chemotherapy Partly Ameliorates These Variations

Deficient Regulatory Innate Lymphoid Cells and Differential Expression of Mirnas in Acute Myeloid Leukemia Quantified by Next Generation Sequence

Elevated Th22 Cells Correlated With Th17 Cells In Peripheral Blood Of Patients With Acute Myeloid Leukemia